The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial
In: Beneficial MicrobesSearch for other papers by K. Airaksinen in
Current site
Google Scholar
Search for other papers by N. Yeung in
Current site
Google Scholar
Search for other papers by A. Lyra in
Current site
Google Scholar
Search for other papers by S.J. Lahtinen in
Current site
Google Scholar
Search for other papers by T. Huttunen in
Current site
Google Scholar
Search for other papers by F. Shanahan in
Current site
Google Scholar
Search for other papers by A.C. Ouwehand in
Current site
Google Scholar
Selected strains of lactobacilli and bifidobacteria are known to ameliorate constipation-related symptoms and have previously shown efficacy on digestive health. In this clinical trial, the safety and effectiveness of a probiotic blend containing lactobacilli and bifidobacteria were evaluated in adults with self-reported bloating and functional constipation. Constipation was diagnosed by the Rome III criteria. A total of 156 adults were randomised into this double-blind and placebo-controlled trial. Participants consumed the combination of Lactobacillus acidophilus NCFM (1010 cfu), Lactobacillus paracasei Lpc-37 (2.5×109 cfu), Bifidobacterium animalis subsp. lactis strains Bl-04 (2.5×109 cfu), Bi-07 (2.5×109 cfu) and HN019 (1010 cfu) (n=78), or placebo (microcrystalline cellulose) (n=78) for two weeks. After treatment the following were measured: primary outcome of bloating and secondary outcomes of colonic transit time, bowel movement frequency, stool consistency, other gastrointestinal symptoms (flatulence, abdominal pain, and burbling), constipation-related questionnaires (PAC-SYM and PAC-QoL) and product satisfaction. Faecal recovery of consumed strains was determined. The enrolled population was defined as constipated, however, the initial bloating severity was lower than in previous similar studies. No clinically significant observations related to the safety of the product were reported. Product efficacy was not shown in the primary analysis for bloating nor for the secondary efficacy analyses. The placebo functioned similarly as the probiotic product. In post-hoc analysis, a statistically significant decrease in flatulence in favour of the probiotic group was observed; day 7 (intention-to-treat (ITT): P=0.0313; per-protocol (PP): 0.0253) and on day 14 (ITT: P=0.0116; PP: P=0.0102) as measured by area under the curve (AUC) analysis. The mean AUC of all symptoms decreased in favour of the probiotic group, indicating less digestive discomfort. The study was registered at the ISRCTN registry (ISRCTN41607808).
-
Bautista Casasnovas, A., Varela Cives, R., Villanueva Jeremias, A., Castro-Gago, M., Cadranel, S. and Tojo Sierra, R., 1991. Measurement of colonic transit time in children. Journal of Pediatric Gastroenterology and Nutrition 13: 42-45.
'Measurement of colonic transit time in children ' () 13 Journal of Pediatric Gastroenterology and Nutrition : 42 -45.
-
Belsey, J., Greenfield, S., Candy, D. and Geraint, M., 2010. Systematic review: impact of constipation on quality of life in adults and children. Alimentary Pharmacology and Therapeutics 31: 938-949.
'Systematic review: impact of constipation on quality of life in adults and children ' () 31 Alimentary Pharmacology and Therapeutics : 938 -949.
-
Bettler, J., Mitchell, D.K. and Kullen, M.J., 2006. Administration of Bifidobacterium lactis with fructo-oligosaccharide to toddlers is safe and results in transient colonization. International Journal of Probiotics and Prebiotics 1 (3-4).
'Administration of Bifidobacterium lactis with fructo-oligosaccharide to toddlers is safe and results in transient colonization ', in International Journal of Probiotics and Prebiotics , () 1.
-
Bingham, S.A., Welch, A.A., McTaggart, A., Mulligan, A.A., Runswick, S.A., Luben, R., Oakes, S., Khaw, K.T., Wareham, N. and Day, N.E., 2001. Nutritional methods in the European prospective investigation of cancer in Norfolk. Public Health Nutrition 4: 847-858.
'Nutritional methods in the European prospective investigation of cancer in Norfolk ' () 4 Public Health Nutrition : 847 -858.
-
Bouchoucha, M., Devroede, G., Arhan, P., Strom, B., Weber, J., Cugnenc, P.H., Denis, P. and Barbier, J.P., 1992. What is the meaning of colorectal transit time measurement? Diseases of the Colon and Rectum 35: 773-782.
'What is the meaning of colorectal transit time measurement? ' () 35 Diseases of the Colon and Rectum : 773 -782.
-
Bouchoucha, M., Devroede, G., Faye, A., Le Toumelin, P., Arhan, P. and Arsac, M., 2006. Colonic responce to food in constipation. International Journal of Colorectal Disease 21: 826-833.
'Colonic responce to food in constipation ' () 21 International Journal of Colorectal Disease : 826 -833.
-
Bouchoucha, M. and Thomas, S.R., 2000. Error analysis of classic colonic transit time estimates. American Journal of Physiology-Gastrointestinal and Liver Physiology 279: G520-527.
'Error analysis of classic colonic transit time estimates ' () 279 American Journal of Physiology-Gastrointestinal and Liver Physiology : G520 -527.
-
Dekker, J.W., Wickens, K., Black, P.N., Stanley, T.V., Mitchell, E.A., Fitzharris, P., Tannock, G.W., Purdie, G. and Crane, J., 2009. Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp. lactis HN019 in human infants aged 0-2 years. International Dairy Journal 19: 149-154.
'Safety aspects of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium animalis subsp ' () 19 International Dairy Journal : 149 -154.
-
Drossman, D.A., 2006. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130: 1377-1390.
'The functional gastrointestinal disorders and the Rome III process ' () 130 Gastroenterology : 1377 -1390.
-
Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Available at: http://tinyurl.com/8bccc3r.
-
Fateh, R., Iravani, S., Frootan, M., Rasouli, M.R. and Saadat, S., 2011. Synbiotic preparation in men suffering from functional constipation: a randomised controlled trial. Swiss Medical Weekly 141: w13239.
'Synbiotic preparation in men suffering from functional constipation: a randomised controlled trial ' () 141 Swiss Medical Weekly : w13239.
-
Favretto, D.C., Pontin, B. and Moreira, T.R., 2013. Effect of the consumption of a cheese enriched with probiotic organisms (Bifidobacterium lactis BI-07) in improving symptoms of constipation. Arquivos de Gastroenterologia 50: 196-201.
'Effect of the consumption of a cheese enriched with probiotic organisms (Bifidobacterium lactis BI-07) in improving symptoms of constipation ' () 50 Arquivos de Gastroenterologia : 196 -201.
-
Francis, C.Y., Morris, J. and Whorwell, P.J., 1997. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Alimentary Pharmacology and Therapeutics 11: 395-402.
'The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress ' () 11 Alimentary Pharmacology and Therapeutics : 395 -402.
-
Frank, L., Kleinman, L., Farup, C., Taylor, L. and Miner, P., 1999. Psychometric validation of a constipation symptom assessment questionnaire. Scandinavian Journal of Gastroenterology 34: 870-877.
'Psychometric validation of a constipation symptom assessment questionnaire ' () 34 Scandinavian Journal of Gastroenterology : 870 -877.
-
Hagstromer, M., Oja, P. and Sjostrom, M., 2006. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutrition 9: 755-762.
'The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity ' () 9 Public Health Nutrition : 755 -762.
-
Hajek, P., Gillison, F. and McRobbie, H., 2003. Stopping smoking can cause constipation. Addiction 98: 1563-1567.
'Stopping smoking can cause constipation ' () 98 Addiction : 1563 -1567.
-
Harris, L.A., 2005. Prevalence and ramifications of chronic constipation. Managed Care Interface 18: 23-30.
'Prevalence and ramifications of chronic constipation ' () 18 Managed Care Interface : 23 -30.
-
Heidelbaugh, J.J., Stelwagon, M., Miller, S.A., Shea, E.P. and Chey, W.D., 2015. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden. American Journal of Gastroenterology 110: 580-587.
'The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden ' () 110 American Journal of Gastroenterology : 580 -587.
-
Hemalatha, R., Ouwehand, A.C., Forssten, S.D., Geddan, J.J.B., Mamidi, R.S., Bhaskar, V. and Radhakrishna, K.V., 2014. Community-based randomized double blind controlled trial of Lactobacillus paracasei and Bifidobacterium lactis on reducing risk for diarrhea and fever in preschool children in an urban slum in India. European Journal of Nutrition and Food Safety 4: 325-341.
'Community-based randomized double blind controlled trial of Lactobacillus paracasei and Bifidobacterium lactis on reducing risk for diarrhea and fever in preschool children in an urban slum in India ' () 4 European Journal of Nutrition and Food Safety : 325 -341.
-
Higgins, P.D. and Johanson, J.F., 2004. Epidemiology of constipation in North America: a systematic review. American Journal of Gastroenterology 99: 750-759.
'Epidemiology of constipation in North America: a systematic review ' () 99 American Journal of Gastroenterology : 750 -759.
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514.
'Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic ' () 11 Nature Reviews Gastroenterology and Hepatology : 506 -514.
-
Ibarra, A., Latreille-Barbier, M., Donazzolo, Y., Pelletier, X. and Ouwehand, A.C., 2018. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: a double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes 9: 236-251.
'Effects of 28-day Bifidobacterium animalis subsp ' () 9 Gut Microbes : 236 -251.
-
Ibarra, A., Olli, K. and Ouwehand, A.C., 2017. Correcting for non-compliance when determining colonic transit time with radio-opaque markers. World Journal of Gastroenterology 23: 740-742.
'Correcting for non-compliance when determining colonic transit time with radio-opaque markers ' () 23 World Journal of Gastroenterology : 740 -742.
-
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 1996. Guideline for Good Clinical Practice. ICH Harmonised Tripartite Guideline. E6(R1). Current Step 4 version, dated 10 June 1996 (including the Post Step 4 corrections). Available at: http://apps.who.int/medicinedocs/en/m/abstract/Js22154en/.
-
Iovino, P., Bucci, C., Tremolaterra, F., Santonicola, A. and Chiarioni, G., 2014. Bloating and functional gastro-intestinal disorders: where are we and where are we going? World Journal of Gastroenterology 20: 14407-14419.
'Bloating and functional gastro-intestinal disorders: where are we and where are we going? ' () 20 World Journal of Gastroenterology : 14407 -14419.
-
Kim, E.R. and Rhee, P.L., 2012. How to interpret a functional or motility test - colon transit study. Journal of Neurogastroenterology and Motililty 18: 94-99.
'How to interpret a functional or motility test - colon transit study ' () 18 Journal of Neurogastroenterology and Motililty : 94 -99.
-
Lehtinen, M.J., Hibberd, A.A., Mannikko, S., Yeung, N., Kauko, T., Forssten, S., Lehtoranta, L., Lahtinen, S.J., Stahl, B., Lyra, A. and Turner, R.B., 2018. Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge. Scientific Reports 8: 11411.
'Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge ' () 8 Scientific Reports : 11411.
-
Lembo, A.J., Kurtz, C.B., Macdougall, J.E., Lavins, B.J., Currie, M.G., Fitch, D.A., Jeglinski, B.I. and Johnston, J.M., 2010. Efficacy of linaclotide for patients with chronic constipation. Gastroenterology 138: 886-895.
'Efficacy of linaclotide for patients with chronic constipation ' () 138 Gastroenterology : 886 -895.
-
Lewis, S.J. and Heaton, K.W., 1997. Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology 32: 920-924.
'Stool form scale as a useful guide to intestinal transit time ' () 32 Scandinavian Journal of Gastroenterology : 920 -924.
-
Locke 3rd, G.R., Pemberton, J.H. and Phillips, S.F., 2000. AGA technical review on constipation. American Gastroenterological Association. Gastroenterology 119: 1766-1778.
'AGA technical review on constipation ' () 119 Gastroenterology : 1766 -1778.
-
Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F. and Spiller, R.C., 2006. Functional bowel disorders. Gastroenterology 130: 1480-1491.
'Functional bowel disorders ' () 130 Gastroenterology : 1480 -1491.
-
Magro, D.O., De Oliveira, L.M., Bernasconi, I., De Souza Ruela, S., Credidio, L., Barcelos, I.K., Leal, R.F., Lourdes Setsuko Ayrizono, M., Fagundes, J.J., De B Teixeira, L., Ouwehand, A.C. and Coy, C.S., 2014. Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation. Nutrition Journal 13: 75.
'Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation ' () 13 Nutrition Journal : 75.
-
Marquis, P., De la Loge, C., Dubois, D., McDermott, A. and Chassany, O., 2005. Development and validation of the patient assessment of constipation quality of life questionnaire. Scandinavian Journal of Gastroenterology 40: 540-551.
'Development and validation of the patient assessment of constipation quality of life questionnaire ' () 40 Scandinavian Journal of Gastroenterology : 540 -551.
-
Metcalf, A.M., Phillips, S.F., Zinsmeister, A.R., MacCarty, R.L., Beart, R.W. and Wolff, B.G., 1987. Simplified assessment of segmental colonic transit. Gastroenterology 92: 40-47.
'Simplified assessment of segmental colonic transit ' () 92 Gastroenterology : 40 -47.
-
Miller, L.E., Ibarra, A. and Ouwehand, A.C., 2017a. Normative values for colonic transit time and patient assessment of constipation in adults with functional constipation: systematic review with meta-analysis. Clinical Medicine Insights: Gastroenterology 10: 1179552217729343.
'Normative values for colonic transit time and patient assessment of constipation in adults with functional constipation: systematic review with meta-analysis ' () 10 Clinical Medicine Insights: Gastroenterology : 1179552217729343.
-
Miller, L.E., Ibarra, A., Ouwehand, A.C. and Zimmermann, A.K., 2017b. Normative values for stool frequency and form using Rome III diagnostic criteria for functional constipation in adults: systematic review with meta-analysis. Annals of Gastroenterology 30: 161-167.
'Normative values for stool frequency and form using Rome III diagnostic criteria for functional constipation in adults: systematic review with meta-analysis ' () 30 Annals of Gastroenterology : 161 -167.
-
Miller, L.E., Ouwehand, A.C. and Ibarra, A., 2017c. Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: systematic review and meta-analysis of randomized controlled trials. Annals of Gastroenterology 30: 629-639.
'Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: systematic review and meta-analysis of randomized controlled trials ' () 30 Annals of Gastroenterology : 629 -639.
-
Miller, L.E., Zimmermann, A.K. and Ouwehand, A.C., 2016. Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit. World Journal of Gastroenterology 22: 5122-5131.
'Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit ' () 22 World Journal of Gastroenterology : 5122 -5131.
-
Ouwehand, A.C., DongLian, C., Weijian, X., Stewart, M., Ni, J., Stewart, T. and Miller, L.E., 2014. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. Vaccine 32: 458-463.
'Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study ' () 32 Vaccine : 458 -463.
-
Raahave, D., Christensen, E., Loud, F.B. and Knudsen, L.L., 2009. Correlation of bowel symptoms with colonic transit, length, and faecal load in functional faecal retention. Danish Medical Bulletin 56: 83-88.
'Correlation of bowel symptoms with colonic transit, length, and faecal load in functional faecal retention ' () 56 Danish Medical Bulletin : 83 -88.
-
Riezzo, G., Orlando, A., D’Attoma, B., Linsalata, M., Martulli, M. and Russo, F., 2018. Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation. Beneficial Microbes 9: 51-60.
'Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation ' () 9 Beneficial Microbes : 51 -60.
-
Ringel-Kulka, T., Goldsmith, J.R., Carroll, I.M., Barros, S.P., Palsson, O., Jobin, C. and Ringel, Y., 2014. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain – a randomised clinical study. Alimentary Pharmacology and Therapeutics 40: 200-207.
'Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain – a randomised clinical study ' () 40 Alimentary Pharmacology and Therapeutics : 200 -207.
-
Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.F., Ardid, D. and Desreumaux, P., 2007. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine 13: 35-37.
'Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors ' () 13 Nature Medicine : 35 -37.
-
Turroni, F., Ventura, M., Butto, L.F., Duranti, S., O’Toole, P.W., Motherway, M.O. and Van Sinderen, D., 2014. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cellular and Molecular Life Sciences 71: 183-203.
'Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective ' () 71 Cellular and Molecular Life Sciences : 183 -203.
-
Waitzberg, D.L., Logullo, L.C., Bittencourt, A.F., Torrinhas, R.S., Shiroma, G.M., Paulino, N.P. and Teixeira-da-Silva, M.L., 2013. Effect of synbiotic in constipated adult women – a randomized, double-blind, placebo-controlled study of clinical response. Clinical Nutrition 32: 27-33.
'Effect of synbiotic in constipated adult women – a randomized, double-blind, placebo-controlled study of clinical response ' () 32 Clinical Nutrition : 27 -33.
-
Waller, P.A., Gopal, P.K., Leyer, G.J., Ouwehand, A.C., Reifer, C., Stewart, M.E. and Miller, L.E., 2011. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scandinavian Journal of Gastroenterology 46: 1057-1064.
'Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults ' () 46 Scandinavian Journal of Gastroenterology : 1057 -1064.
-
World Medical Association (WMA), 2013. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. World Medical Association Declaration of Helsinki, 7th edition. JAMA 310: 2191-2194. DOI: https://doi.org/10.1001/jama.2013.281053
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 1157 | 499 | 30 |
| PDF Views & Downloads | 1642 | 711 | 48 |
The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial
In: Beneficial MicrobesSearch for other papers by K. Airaksinen in
Current site
Google Scholar
PubMed
Search for other papers by N. Yeung in
Current site
Google Scholar
PubMed
Search for other papers by A. Lyra in
Current site
Google Scholar
PubMed
Search for other papers by S.J. Lahtinen in
Current site
Google Scholar
PubMed
Search for other papers by T. Huttunen in
Current site
Google Scholar
PubMed
Search for other papers by F. Shanahan in
Current site
Google Scholar
PubMed
Search for other papers by A.C. Ouwehand in
Current site
Google Scholar
PubMed
Selected strains of lactobacilli and bifidobacteria are known to ameliorate constipation-related symptoms and have previously shown efficacy on digestive health. In this clinical trial, the safety and effectiveness of a probiotic blend containing lactobacilli and bifidobacteria were evaluated in adults with self-reported bloating and functional constipation. Constipation was diagnosed by the Rome III criteria. A total of 156 adults were randomised into this double-blind and placebo-controlled trial. Participants consumed the combination of Lactobacillus acidophilus NCFM (1010 cfu), Lactobacillus paracasei Lpc-37 (2.5×109 cfu), Bifidobacterium animalis subsp. lactis strains Bl-04 (2.5×109 cfu), Bi-07 (2.5×109 cfu) and HN019 (1010 cfu) (n=78), or placebo (microcrystalline cellulose) (n=78) for two weeks. After treatment the following were measured: primary outcome of bloating and secondary outcomes of colonic transit time, bowel movement frequency, stool consistency, other gastrointestinal symptoms (flatulence, abdominal pain, and burbling), constipation-related questionnaires (PAC-SYM and PAC-QoL) and product satisfaction. Faecal recovery of consumed strains was determined. The enrolled population was defined as constipated, however, the initial bloating severity was lower than in previous similar studies. No clinically significant observations related to the safety of the product were reported. Product efficacy was not shown in the primary analysis for bloating nor for the secondary efficacy analyses. The placebo functioned similarly as the probiotic product. In post-hoc analysis, a statistically significant decrease in flatulence in favour of the probiotic group was observed; day 7 (intention-to-treat (ITT): P=0.0313; per-protocol (PP): 0.0253) and on day 14 (ITT: P=0.0116; PP: P=0.0102) as measured by area under the curve (AUC) analysis. The mean AUC of all symptoms decreased in favour of the probiotic group, indicating less digestive discomfort. The study was registered at the ISRCTN registry (ISRCTN41607808).
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 1157 | 499 | 30 |
| PDF Views & Downloads | 1642 | 711 | 48 |
